These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27911436)

  • 21. Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximab.
    Kobayashi T; Tsutsumi Y; Sakamoto N; Nagoshi H; Yamamoto-Sugitani M; Shimura Y; Mizutani S; Matsumoto Y; Nishida K; Horiike S; Asano N; Nakamura S; Kuroda J; Taniwaki M
    Jpn J Clin Oncol; 2012 Nov; 42(11):1035-42. PubMed ID: 22984125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
    Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
    Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
    Kiewe P; Thiel E
    Ann Hematol; 2011 Jan; 90(1):109-10. PubMed ID: 20387065
    [No Abstract]   [Full Text] [Related]  

  • 24. CD5(-) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single case.
    Lucioni M; Novara F; Riboni R; Fiandrino G; Nicola M; Kindl S; Boveri E; Jemos V; Arcaini L; Zuffardi O; Paulli M
    Hum Pathol; 2011 Aug; 42(8):1204-8. PubMed ID: 21334716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.
    Aoki T; Shimada K; Sakamoto A; Sugimoto K; Morishita T; Kojima Y; Shimada S; Kato S; Iriyama C; Kuno S; Harada Y; Tomita A; Hayakawa F; Kiyoi H
    Oncotarget; 2017 Feb; 8(8):13085-13098. PubMed ID: 28055963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjunctival lymphoma in a child.
    Waisbourd M; Leibovitch I; Sayar D; Elhasid R
    Cornea; 2011 May; 30(5):598-9. PubMed ID: 21107252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment.
    Hitz F; Connors JM; Gascoyne RD; Hoskins P; Moccia A; Savage KJ; Sehn LH; Shenkier T; Villa D; Klasa R
    Ann Hematol; 2015 Nov; 94(11):1839-43. PubMed ID: 26246466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.
    Camicia R; Winkler HC; Hassa PO
    Mol Cancer; 2015 Dec; 14():207. PubMed ID: 26654227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
    Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary cutaneous diffuse large B-cell lymphoma, leg type: report of a case].
    Lu XY; Lu C; Yin YL; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):416-7. PubMed ID: 21055163
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular outcome prediction in diffuse large-B-cell lymphoma.
    Alizadeh AA; Gentles AJ; Lossos IS; Levy R
    N Engl J Med; 2009 Jun; 360(26):2794-5. PubMed ID: 19553658
    [No Abstract]   [Full Text] [Related]  

  • 32. Diffuse large B-cell lymphoma.
    Habermann TM
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):suppl 4-5. PubMed ID: 16491628
    [No Abstract]   [Full Text] [Related]  

  • 33. Macrophage colony-stimulating factor produced by diffuse large B-cell lymphoma.
    Nakayama-Ichiyama S; Yokote T; Oka S; Takubo T; Tsuji M; Hanafusa T
    Br J Haematol; 2010 May; 149(3):310. PubMed ID: 20085576
    [No Abstract]   [Full Text] [Related]  

  • 34. Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.
    Scandurra M; Mian M; Greiner TC; Rancoita PM; De Campos CP; Chan WC; Vose JM; Chigrinova E; Inghirami G; Chiappella A; Baldini L; Ponzoni M; Ferreri AJ; Franceschetti S; Gaidano G; Montes-Moreno S; Piris MA; Facchetti F; Tucci A; Nomdedeu JF; Lazure T; Lambotte O; Uccella S; Pinotti G; Pruneri G; Martinelli G; Young KH; Tibiletti MG; Rinaldi A; Zucca E; Kwee I; Bertoni F
    Br J Haematol; 2010 Nov; 151(3):221-31. PubMed ID: 20813005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
    Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
    Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
    Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
    Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refractory IGκ/IRF4-positive DLBCL with CDKN2A/2B deletion.
    Chonabayashi K; Tamori S; Taniwaki M; Fujita H; Shimazu Y; Matsui Y; Hishizawa M; Usami K; Takaori-Kondo A
    Ann Hematol; 2014 May; 93(5):893-4. PubMed ID: 23989669
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma.
    Ohsawa M; Ikura Y; Fukushima H; Shirai N; Sugama Y; Suekane T; Hirayama M; Hino M; Ueda M
    Oncology; 2005; 68(4-6):422-31. PubMed ID: 16020972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactic Acidosis and Hypoglycemia in a Patient with Gastric Diffuse Large B-Cell Lymphoma due to the Warburg Effect.
    Hamada T; Kaku T; Mitsu S; Morita Y; Ohno N; Yamaguchi H
    Case Rep Oncol; 2020; 13(2):1047-1052. PubMed ID: 33082747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of CCR4 in diffuse large B-cell lymphoma, not otherwise specified.
    Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Hiraoka N; Takayama A; Nishiwaki U; Masuda Y; Nishimura Y; Tsuji M; Hanafusa T
    Leukemia; 2013 Dec; 27(12):2382-5. PubMed ID: 23612017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.